Clinical trial
A Randomized, Two-arm, Open Label Study to evalUate the Effect of a Smart Phone-based Patient Support Tool On Patient AdheRence of Treatment in Stable Angina Patients Prescribed Beta-blockers in China (SUPPORT)
NCT03794713 is registered in ClinicalTrials.gov with Shenyang Northern Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized, Two-arm, Open Label Study to evalUate the Effect of a Smart Phone-based Patient Support Tool On Patient AdheRence of Treatment in Stable Angina Patients Prescribed Beta-blockers in China (SUPPORT)
- Lead sponsor
- Shenyang Northern Hospital
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- April 1, 2019
- Completion date
- September 1, 2020
- Enrollment
- 432 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
adrenergic beta-antagonists, medication adherence, mobile applications, stable angina pectoris